U.S. market Open. Closes in 48 minutes

BBC | Virtus LifeSci Biotech Clinical Trials ETF Overview

(Stock Exchange: AMEX)
Day's Range 25.94 - 26.11
52 Week Range 18.77 - 31.99
Beta 1.00
Implied Volatility 31.84%
IV Rank 70.94%
Day's Volume 1,821
Average Volume 1,820
Shares Outstanding 428,665
Inception Date 2014-12-17
Assets 10,385,303
Asset Class Equity
Expense Ratio 0.79
P/E Ratio N/A
EPS N/A
Dividend Yield 0.31%
Dividend Per Share 0.08
Dividend ExDate N/A
Dividend PayDate N/A
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
*Chart delayed
Watching at BBC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BBC Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙